Tahereh Javaheri
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Oncology top 5%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
Papers in
-
- RNA Interference and Gene Delivery 6
- Advanced biosensing and bioanalysis techniques 5
- Ubiquitin and proteasome pathways 3
- CRISPR and Genetic Engineering 2
- Oncology 6
- Cancer Cells and Metastasis 3
- Co-authors
- Khaled Seidi (12 shared papers)Rana Jahanban‐Esfahlan (10 shared papers)Mehdi Jaymand (7 shared papers)Payman Zare (8 shared papers)Abbas Ebrahimi‐Kalan (1 shared paper)Leila Roshangar (1 shared paper)Roghayyeh Baghban (1 shared paper)Saeed Kolahian (1 shared paper)
- Journals
- Oncotarget (2 papers)Advanced Functional Materials (2 papers)Journal of Controlled Release (2 papers)Oncogene (1 paper)Molecular Pharmacology (1 paper)
- Partner nations
- AustriaIranUnited States
In The Last Decade
Tahereh Javaheri
19 papers receiving 2.5k citations
Tahereh Javaheri's Hit Papers
Peers
Comparison fields: 5 of 122
- Cancer Research 508
- Oncology 742
- Molecular Medicine 117
- Biomaterials 309
- Immunology 419
Countries citing papers authored by Tahereh Javaheri
This map shows the geographic impact of Tahereh Javaheri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tahereh Javaheri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tahereh Javaheri more than expected).
Fields of papers citing papers by Tahereh Javaheri
This network shows the impact of papers produced by Tahereh Javaheri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tahereh Javaheri. The network helps show where Tahereh Javaheri may publish in the future.
Co-authors
The 25 scholars most cited alongside Tahereh Javaheri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Tumor microenvironment complexity and therapeutic implications at a glance Hit paper breakdown → | 2020 | 1307 |
| 2 | 2020 | 206 | |
| 3 | 2016 | 182 | |
| 4 | 2020 | 132 | |
| 5 | 2018 | 130 | |
| 6 | 2020 | 110 | |
| 7 | 2019 | 90 | |
| 8 | 2021 | 68 | |
| 9 | 2019 | 48 | |
| 10 | 2017 | 48 | |
| 11 | 2021 | 48 | |
| 12 | 2018 | 45 | |
| 13 | 2019 | 38 | |
| 14 | 2018 | 32 | |
| 15 | 2010 | 23 | |
| 16 | 2015 | 19 | |
| 17 | 2016 | 10 | |
| 18 | Static DNA Nanostructures For Cancer Theranostics: Recent Progress In Design And Applications | 2019 | 2 |
| 19 | 2025 | 1 | |
| 20 | 2014 | 0 |
About Tahereh Javaheri
Tahereh Javaheri is a scholar working on Molecular Biology, Oncology, Cancer Research, Immunology and Biomedical Engineering, having authored 22 papers that have together received 2.5k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Advanced biosensing and bioanalysis techniques (5 papers), Ubiquitin and proteasome pathways (3 papers), Cancer Cells and Metastasis (3 papers), Sarcoma Diagnosis and Treatment (2 papers), MicroRNA in disease regulation (2 papers), 3D Printing in Biomedical Research (2 papers) and CRISPR and Genetic Engineering (2 papers). The work is most often cited by research in Cancer Research (508 citations), Oncology (742 citations), Molecular Medicine (117 citations), Biomaterials (309 citations) and Immunology (419 citations). Tahereh Javaheri has collaborated with scholars based in Austria, Iran and United States. Frequent co-authors include Khaled Seidi, Rana Jahanban‐Esfahlan, Mehdi Jaymand, Payman Zare, Abbas Ebrahimi‐Kalan, Leila Roshangar, Roghayyeh Baghban, Saeed Kolahian, Richard Moriggl and Ali Jahanban‐Esfahlan. Their work appears in journals such as Oncotarget, Advanced Functional Materials, Journal of Controlled Release, Oncogene and Molecular Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.